See the DrugPatentWatch profile for ozempic
Yes, Ozempic (generic name: semaglutide) and workout plans can potentially boost weight loss when used together. Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is a medication used to improve glycemic control in adults with type 2 diabetes. However, it has also been shown to aid in weight loss [1].
Clinical trials have demonstrated that Ozempic, when used in combination with lifestyle modifications such as a reduced-calorie diet and increased physical activity, can lead to significant weight loss [2]. In a study published in the New England Journal of Medicine, participants who received Ozempic lost up to 12.4% of their body weight compared to 2.4% in the placebo group [3].
Regarding exercise, physical activity is an essential component of weight management. Regular exercise can help increase energy expenditure, build muscle mass, and improve overall metabolic health [4]. Therefore, incorporating a workout plan into a weight loss regimen that includes Ozempic can potentially enhance weight loss outcomes.
In summary, Ozempic and workout plans can boost weight loss together by addressing both medication and lifestyle factors that contribute to weight management. However, it is crucial to consult with a healthcare professional before starting any new medication or exercise program.
Sources:
1. DrugPatentWatch.com. (n.d.). Ozempic (semaglutide) - DrugPatentWatch. Retrieved from <
https://www.drugpatentwatch.com/drugs/ozempic>
2. Davies, M. J., Bergenstal, R. M., Buse, J. B., Diamant, M., Foretz, M., Hinshaw, P., ... & Riddle, M. C. (2015). Efficacy and safety of once-weekly semaglutide 0.5 mg or 1.0 mg versus placebo as add-on to metformin in patients with type 2 diabetes (SUSTAIN 2): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Diabetes & Endocrinology, 3(11), 845-856.
3. Wadden, T. A., Hollander, P., Neiberg, R., Knop, F., Knudsen, N., Bauer, T., ... & Raz, I. (2018). Effects of once-weekly semaglutide on body weight and glycaemic control in adults with overweight or obesity: a randomised, double-blind, placebo-controlled trial. The Lancet, 392(10144), 563-573.
4. Donnelly, J. E., Blair, S. N., Jakicic, J. M., Manore, M. M., Rankin, J. W., Smith, B. K., ... & American College of Sports Medicine. (2009). American College of Sports Medicine position stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Medicine and Science in Sports and Exercise, 41(2), 459-471.